Two Sigma Securities’s Allarity Therapeutics ALLR Stock Holding History

Two Sigma Securities’s Portfolio ALLR Stock Details ALLR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,334	Closed	-$13.4K	–	1699
2026 Q1	$13.4K	Sell	12,334 -1,260	-9%	-$1.36K	﹤0.01%	1436
2025 Q4	$14.7K	Buy	+13,594	New	+$17.3K	﹤0.01%	1231
2024 Q1	–	Sell	-63	Closed	-$20.7K	–	2919
2023 Q4	$20.7K	Buy	63 +42	+200%	+$14.6K	﹤0.01%	2719
2023 Q3	$9.4K	Buy	+21	New	+$26.9K	﹤0.01%	2703
2023 Q1	–	Hold	0	–	-$3.68K	–	2606
2022 Q4	–	Hold	0	–	–	–	2483

Other funds holding ALLR

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MCM

Militia Capital Management Austin, Texas $3.37B AUM

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Two Sigma Securities's ALLR Position: Q2 2026 in Review

Two Sigma Securities sold out of Allarity Therapeutics (ALLR) in Q2 2026, closing a stake of 12,334 shares — an estimated $13.4K sold.

Two Sigma Securities first reported a position in ALLR in Q3 2023 and held it in 4 quarters. The position peaked at $20.7K in Q4 2023. 19 funds tracked by Wall St. Rank hold ALLR as of Q2 2026.

Two Sigma Securities reported no remaining Allarity Therapeutics position as of Q2 2026 after selling out during the quarter.
Two Sigma Securities sold 12,334 Allarity Therapeutics shares in Q2 2026, an estimated $13.4K.
Two Sigma Securities first reported a position in Allarity Therapeutics in Q3 2023 and held it in 4 quarters.
Two Sigma Securities's Allarity Therapeutics position peaked at $20.7K in Q4 2023.
19 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.